Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors.
about
Abronione, a rotenoid from the desert annual Abronia villosaMechanisms of drug resistance in colon cancer and its therapeutic strategiesPotent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusaDeterminants of the activity and substrate recognition of breast cancer resistance protein (ABCG2).Antibacterial activities of the methanol extracts of Albizia adianthifolia, Alchornea laxiflora, Laportea ovalifolia and three other Cameroonian plants against multi-drug resistant Gram-negative bacteria.Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring positionPhytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn.ABCG2 transports and transfers heme to albumin through its large extracellular loopPredicting substrates of the human breast cancer resistance protein using a support vector machine method.Medicinal plants used as antitumor agents in Brazil: an ethnobotanical approachThe challenge of exploiting ABCG2 in the clinic.Inhibition of Human Cervical Cancer Cell Growth by Ethanolic Extract of Boerhaavia diffusa Linn. (Punarnava) Root.Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.Cytotoxicity of methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell linesBCRP Inhibition: from Data Collection to Ligand-Based Modeling.Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.New structure-activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity.Structure-activity relationships and quantitative structure-activity relationships for breast cancer resistance protein (ABCG2).Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicityABCG2: recent discovery of potent and highly selective inhibitors.Natural product modulators to overcome multidrug resistance in cancer.A new diphenyl ether derivative from Mirabilis himalaica.ABCG2/BCRP: Specific and Nonspecific Modulators.Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and Intracellular Invasion of Bacteria.Design and development of a stable polyherbal formulation based on the results of compatibility studies.Advances in Boerhaavia diffusa hairy root technology: a valuable pursuit for identifying strain sensitivity and up-scaling factors to refine metabolite yield and bioactivity potentials.Quantitative analysis of boeravinones in the roots of Boerhaavia Diffusa by UPLC/PDA.Anti-inflammatory potential of a lipid-based formulation of a rotenoid-rich fraction prepared from Boerhavia diffusa.
P2860
Q24632579-5A552E4A-2AD0-4708-BB9D-4BF9EEB97AC8Q26738528-A1CB291F-E667-4F8E-B7BF-8EC90211D374Q28478207-63F0BC97-2FF6-4276-B232-9D58BBB3E6CDQ30364846-4B408AD9-6CB1-4866-914E-211E12C87460Q33632649-AE4AE134-7166-47EC-8305-1DC76E1FE153Q33706574-F49C7C4A-868D-4411-AA84-DF2CB64128ABQ33739924-3DECA830-1264-4E19-B38F-62C8F3353989Q34236666-B8FE7F97-52E0-4EFB-81FC-184CBC856E4BQ34668324-BEDAC0E3-F2BC-4AE1-B1E4-E21109EADE3BQ34853671-F4998FF6-E30C-4EE4-8CDE-09FA1CCCB404Q34968909-98116306-C282-4212-924A-49B0DDE8AD6EQ35174459-50AA9A35-1D9A-42EF-9B36-BE069824295FQ35915497-BB2EFA7E-9610-4026-B366-5967E127D94DQ36093027-E1A643C8-D2C2-4B06-BC7B-C27C9F7E0626Q36093462-4873C14F-3AAF-46A7-BBAC-8B2E43299A83Q36382856-5CDCD9D0-7A83-42F7-8CF6-4FCED033A4E6Q37076348-8FC92708-BB20-4A4C-937D-12C291D915C7Q37221083-DDF9203C-4DB5-4A0A-8B28-DC7B51F7FFC5Q37560771-0C2AEE82-47E9-44DD-A4C1-775866319B57Q37698421-BC903DDD-FB09-4BD6-BB59-F6E6F6BC1B95Q38111799-03A6EE68-C59A-4A6C-88CC-B4C4347A6077Q38343461-A4D62AB7-C118-4724-BB95-0F30AE83A39EQ38727102-EB566ED3-D15F-4B6F-817D-38F292BEC45BQ39049159-4814F8CE-0850-400D-8349-7E3589DF44CBQ42372809-1079AB36-CD79-4152-98F1-D100715976BCQ42785341-1AF1C317-1078-40BA-9140-693F5150050FQ51792436-FD99C57F-FEEF-46A4-8AFC-913873F28744Q53092591-3107CA8A-6660-4E7B-A3EA-FC30777FF2D3Q53548878-1CE93F43-5708-4E4E-9C5B-E6D7F1A4D1A0
P2860
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@ast
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@en
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@nl
type
label
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@ast
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@en
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@nl
prefLabel
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@ast
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@en
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@nl
P2093
P356
P1476
Nonprenylated rotenoids, a new ...... resistance protein inhibitors.
@en
P2093
Abdelhakim Ahmed-Belkacem
Attilio Di Pietro
Francesca Borrelli
Orazio Taglialatela-Scafati
Raffaele Capasso
Sira Macalou
P304
P356
10.1021/JM061450Q
P407
P577
2007-03-07T00:00:00Z